Approval for changes to the materials, color, antenna design, coolant path functions and design of the cooled thermocath catheter.  The device, as modified, will be marketed under the trade name ctc advance and is indicated to relieve symptoms and obstruction associated with benign prostatic hyperplasia (bph) and is indicated for men with prostatic urethra lengths of 3.5 ? 5.0 cm (model number tc1121c) or 4.5+ cm (model number tf1221c).